August 2012
-
Inhalation Sciences (ISAB) announced that it has sold all of its remaining shares in its spinoff Ziccum AB, a spray drying specialist, for a total of approximately SEK 21.2 million. In May 2019, ISAB announced that… Read more . . .
-
Less than two weeks after announcing the promotion of Mike Motion from Chief Commercial Officer to Chief Operating Officer, inhaler monitoring company Adherium has named Motion as its new CEO, replacing interim CEO Jeremy Curnock… Read more . . .
-
Alpha Cognition Inc. (formerly Neurodyn Cognition) and CRO Linical have announced Linical will provide consulting services related to potential development of Alpha Cognition’s Alpha-1062 acetyl choline esterase inhibitor (AChEI) for the treatment of Alzheimer’s disease.… Read more . . .
-
Biomarck Pharmaceuticals said that a Phase 2a clinical trial of its BIO-11006 inhalation solution in patients with acute respiratory distress syndrome (ARDS) met its primary endpoint, with a 43% decrease in mortality at 28 days… Read more . . .
-
Theravance Biopharma said that a Phase 1 study of its TD-0903 nebulized JAK inhibitor is now underway. Earlier this month, Theravance announced that it intended to begin clinical development of TD-0903 for the prevention of… Read more . . .
-
Intranasal vaccine developer BlueWillow Biologics has announced the appointment of Chad Costley as Chief Medical Officer. Costley, an Atlanta-based primary care physician, has previously served on BlueWillow’s board of directors. BlueWillow, formerly known as NanoBio, has a… Read more . . .
-
The FDA has approved an Aurobindo ANDA for generic albuterol (salbutamol) sulfate inhalation solution and, while the agency did not issue a press release, the news was included in the FDA’s COVID-19 “Daily Roundup” and… Read more . . .
-
Aptar has announced a new collaboration agreement with Chinese connected drug delivery specialist Sonmol for development of an inhaler monitoring system designed to “enable remote patient monitoring, improve patient and physician interactions, increase patient engagement… Read more . . .
-
With the transformation of RDD 2020 into Digital RDD 2020 due to the COVID-19 pandemic, one of the biggest questions has been whether previously booked exhibitors would still choose to participate in the technology exhibition.… Read more . . .
-
3P Innovation’s Fill2Weight powder micro-dosing system, which was designed specifically for filling dry powder inhalation formulations, has been awarded the Queen’s Award for Enterprise in Innovation. The Fill2Weight technology is scalable and can be used… Read more . . .
Featured event:
5th Annual Inhaled & Nasal Biologics | DNA Forum
5th Annual Inhaled & Nasal Biologics | DNA Forum
24th-25th September 2026, Cambridge, UK
Join us for a ground-breaking and insightful forum: Two days of cutting-edge talks and networking opportunities in this complex area of drug and vaccine development.
With renowned industry leaders who will share their insights and real-world case studies, our speakers will explore innovative formulation and delivery technologies and the rationale behind overcoming development challenges. Don’t miss out on this opportunity to learn more about key topics shaping the future of inhaled therapeutics.
Get online to see speakers announced so far. Registration is live – save your seat now!
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.